In the patient cohort we analyzed, PBK/TOPK is associated with poorly differentiated prostate cancer, its nuclear localization is strongly correlated with metastatic prostate cancer, and β-catenin is important for mediating the aggressive outcome of PBK expression in vitro. The gene discussed is PBK; the disease is prostate carcinoma.